Admiral Shares Set for Monday Focus After Dividend, Flock News

Admiral Shares Set for Monday Focus After Dividend, Flock News

June 7, 2026

LONDON, June 6, 2026, 23:04 BST

Admiral Group’s shares in London edged up on Friday, closing at 3,294p, a gain of 0.98% for the day. For the week, the shares barely moved, ending just 2p under the previous Friday’s finish. A dividend and a minor deal kept the motor insurer in focus. Data from show the weekly change was minimal.

The London Stock Exchange is closed for the weekend, so traders won’t get another chance to price the stock until Monday, June 8. The exchange runs from 8:00 a.m. to 4:30 p.m. London time, Monday through Friday. For now, this is a weekend wrap, not a move happening in real-time.

Admiral closed out Friday with gains that outpaced the FTSE 100, which put on 0.07%. The FTSE 100 was still down over the week, according to Reuters, as traders watched ongoing inflation pressure related to the Middle East war and UK firms’ pricing moves.

Admiral shares closed with a sell price at 3,312p and a buy price at 3,314p, up 32p, according to Fidelity. The prices were last updated after the market closed on June 5. Admiral is listed in property and casualty insurance and trades on the LSE.

Admiral paid out its final dividend the same day. The company had set a 90.0p final dividend per share, with 72.8p as the normal payout and 17.2p as a special dividend. It reported 2025 profit before tax from continuing operations of £957.9 million, up 16%. Chief Executive Milena Mondini de Focatiis said 2025 was an “exceptional year” and pointed to UK motor profit topping £1 billion. Admiral Group Plc

Admiral wrapped up its acquisition of Flock on Monday after getting regulatory approval, with the deal valuing the digital fleet insurer’s equity at 80 million pounds. Flock works with telemetry to assess driving risk and will be integrated as Admiral’s fleet insurance unit. Emma Huntington, who leads Admiral Pioneer, said the move lets Admiral work with fleet clients “at scale”; Flock boss Ed Leon Klinger said the partnership puts the company into “a much bigger share of the UK motor market.” Investegate

Admiral’s latest deal doesn’t move the needle much on market value, but it’s in line with the plan management’s been talking up: focus on UK motor, build out more data products, and take a measured step toward adjacent markets. Reuters has Admiral down as a provider of motor, household, travel and pet insurance, plus personal lending. UK Insurance and European Insurance are listed as major business segments.

Aviva is still facing tough competition. After its £3.7 billion deal for Direct Line, Aviva is the main listed UK insurer that investors look to for signals on car and home insurance pricing. Reuters said in March that Aviva’s 2025 profit was up 25% and that it restarted buybacks after closing the Direct Line purchase.

Matt Britzman, senior equity analyst at Hargreaves Lansdown, said after Admiral’s results that focus has shifted to a softer spell for motor insurance. He said profit growth is “likely off the cards” in 2026. Britzman flagged claims inflation, pricing pressure and regulatory risks as the main concerns. He said Admiral’s data-driven underwriting and reinsurance ties are positives. Reinsurance passes some insurance risk to another company, reducing capital strain but also capping retained profit on certain policies. Hargreaves Lansdown

But the risks are clear. UK motor premiums could drop again, repair and claim costs may go up, or regulators might get tougher on products like premium finance—monthly insurance payment plans that can come with interest. Admiral’s margins could shrink in that case. The Financial Conduct Authority in February said premium finance costs had declined, but it will keep an eye on prices and use oversight tools as needed.

Admiral has no scheduled trading before the LSE opens again, and the next listed company event is the half-year report in August 2026. So Monday’s move is likely to track the FTSE, insurance group sentiment, or new info on Flock integration, not anything announced directly by Admiral.

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) Valuation Update Following United Imaging Collaboration and Phase 3 Trial News
    June 6, 2026, 6:41 PM EDT. Telix Pharmaceuticals (ASX:TLX) has inked a U.S.-focused collaboration with United Imaging, aiming to integrate theranostics technologies to refine cancer imaging protocols. The partnership centers on TLX101-Px in the U.S., potentially expanding to other products and markets. Following recent Phase 3 TLX591-Tx data, Telix's share price rose to A$13.31, marking a 24% return over 90 days but a nearly 48% decline over one year. Analysts value the stock at A$18.00, suggesting it is 26% undervalued. The company faces high-risk, high-reward prospects tied to revenue growth, margin improvement, and trial outcomes as it builds infrastructure and commercial foothold in molecular imaging and oncology diagnostics.